Q1 2022 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Welcome to the Navidea Biopharma's First Quarter 2021 Earnings Call and Business Update.
I will now turn the call over to the Chief Medical Officer for Navidea, Michael Rosol. You may begin.
Thank you, and thank you all for joining us for today's earnings call. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting a live Q&A session. Navidea's Vice President of Finance and Administration, Erika Eves will be joining me on the call today. .
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic matters as well as the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |